UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Police raids health ministry, Gil hospital over bribery
The South Korean police on Wednesday raided the Ministry of Health and Welf...
by Kwak Sung-sun
|
2017-12-21 12:38
라인
LG Chem’s diabetes drug Zemiglo sees fast sales growth
LG Chem said Wednesday that accumulated, combined sales of diabetes drug Ze...
by Lee Han-soo
|
2017-12-21 12:35
라인
Anti-trust watchdog to probe conglomerates' nonprofit units
The Fair Trade Commission (FTC) Wednesday launched a probe into 57 nonprofi...
by Marian Chu
|
2017-12-21 12:28
라인
Huons Global starts local clinical trial for Hutox
Huons Global said Thursday that it has launched phase 3 local clinical tria...
by Lee Han-soo
|
2017-12-21 11:30
라인
Study finds optimal time for getting postoperative chemotherapy for ovarian cancer
New research says ovarian cancer patients should get postoperative adjuvant...
by Marian Chu
|
2017-12-20 17:31
라인
Huons, SMB sign license agreement for Zephirus
Huons, a subsidiary of Huons Global, said Wednesday that it has signed a li...
by Lee Han-soo
|
2017-12-20 17:07
라인
HanAll inks $30 million tech export deal
HanAll Biopharma said it signed a $30 million deal with a U.S. company to t...
by So Jae-hyeon
|
2017-12-20 15:49
라인
₩500-billion Invossa technology export to Japan in peril
Mitsubishi Tanabe Pharma notified Kolon Life Science that the Japanese drug...
by Nam Doo-hyun
|
2017-12-20 14:59
라인
FDA to review Samsung Bioepis’ trastuzumab biosimilar
Samsung Bioepis said Tuesday that the U.S. Food and Drug Administration (FD...
by Lee Han-soo
|
2017-12-20 14:37
라인
SK Chemicals starts domestic supply of ‘Skyzoster’
SK Chemicals said Tuesday that it has started to supply Skyzoster, the firs...
by Lee Han-soo
|
2017-12-20 14:37
라인
AstraZeneca to test asthma treatment in Korea
AstraZeneca Korea is soon to test the efficacy and safety of tezepelumab, a...
by Lee Hye-seon
|
2017-12-20 13:11
라인
KCDC develops cheaper, efficient way to predict Alzheimer’s
Doctors can now predict Alzheimer’s for patients with mild cognitive impair...
by Marian Chu
|
2017-12-20 12:48
라인
Health ministry to foster healthcare as growth industry
The Ministry of Health and Welfare announced Wednesday its plans to foster ...
by Lee Han-soo
|
2017-12-20 12:45
라인
Identical DNA sequencing found in bacteria in dead newborns
The Korea Centers for Disease Control and Prevention said Wednesday it foun...
by Kwak Sung-sun
|
2017-12-20 11:30
라인
Pfizer gets nod for Gleevec-topping leukemia drug
Pfizer said Tuesday that the U.S. Food and Drug Administration gave an earl...
by Marian Chu
|
2017-12-20 11:08
라인
Exelixis gets early FDA okay to use cancer drug
Exelixis has won the U.S. Food and Drug Administration’s expanded approval ...
by Marian Chu
|
2017-12-20 10:37
라인
FDA approves gene therapy for rare form of inherited vision loss
The U.S. Food and Drug Administration Tuesday approved Spark Therapeutic’s ...
by Lee Han-soo
|
2017-12-20 10:36
라인
Nature Cell expects to receive conditional approval for Jointstem
Nature Cell showed confidence in obtaining conditional approval for Jointst...
by Lee Han-soo
|
2017-12-19 18:22
라인
Ferring’s oral colonoscopy preparation solution obtains FDA approval
Pharmbio Korea said Tuesday that Ferring Pharmaceuticals, a multi-national ...
by Lee Han-soo
|
2017-12-19 17:02
라인
GemVax wins patent for personalized-tissue engineered vein technology
GemVax Technology, a subsidiary of GemVax & KAEL, said Monday that it has a...
by Lee Han-soo
|
2017-12-19 16:16
-
이전
251
252
253
254
255
256
257
258
259
260
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top